JP2013514811A5 - - Google Patents

Download PDF

Info

Publication number
JP2013514811A5
JP2013514811A5 JP2012546131A JP2012546131A JP2013514811A5 JP 2013514811 A5 JP2013514811 A5 JP 2013514811A5 JP 2012546131 A JP2012546131 A JP 2012546131A JP 2012546131 A JP2012546131 A JP 2012546131A JP 2013514811 A5 JP2013514811 A5 JP 2013514811A5
Authority
JP
Japan
Prior art keywords
bmp
variant
cell
item
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012546131A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013514811A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/061437 external-priority patent/WO2011087768A1/en
Publication of JP2013514811A publication Critical patent/JP2013514811A/ja
Publication of JP2013514811A5 publication Critical patent/JP2013514811A5/ja
Pending legal-status Critical Current

Links

JP2012546131A 2009-12-22 2010-12-21 免疫原性が抑制されたbmp−7変異体 Pending JP2013514811A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28922009P 2009-12-22 2009-12-22
US61/289,220 2009-12-22
PCT/US2010/061437 WO2011087768A1 (en) 2009-12-22 2010-12-21 Bmp-7 variants with reduced immunogenicity

Publications (2)

Publication Number Publication Date
JP2013514811A JP2013514811A (ja) 2013-05-02
JP2013514811A5 true JP2013514811A5 (https=) 2014-01-09

Family

ID=43735952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546131A Pending JP2013514811A (ja) 2009-12-22 2010-12-21 免疫原性が抑制されたbmp−7変異体

Country Status (7)

Country Link
US (1) US20130190236A1 (https=)
EP (1) EP2516456A1 (https=)
JP (1) JP2013514811A (https=)
CN (1) CN102822197A (https=)
AU (1) AU2010341565A1 (https=)
CA (1) CA2785038A1 (https=)
WO (1) WO2011087768A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3197474B1 (en) 2014-09-26 2023-06-07 Rajendra Sahai Bhatnagar Inhibitors of nf kappa-b activity for treatment of diseases and disorders
AU2015374114B2 (en) 2014-12-29 2018-07-26 Bioventus, Llc Systems and methods for improved delivery of osteoinductive molecules in bone repair
WO2019148140A2 (en) * 2018-01-26 2019-08-01 Wu Joseph C Implantable biomaterials that enhance stem cell survival and function

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US6919308B2 (en) 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
CA2085134C (en) 1990-06-15 2003-03-18 Carnegie Institution Of Washington Gdf-1
US6506729B1 (en) 1991-03-11 2003-01-14 Curis, Inc. Methods and compositions for the treatment and prevention of Parkinson's disease
US5656593A (en) 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
US5849686A (en) 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US5674844A (en) 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US6800603B2 (en) 1991-03-11 2004-10-05 Curis, Inc. Morphogen-induced neural cell adhesion
US6949505B1 (en) 1991-03-11 2005-09-27 Curis, Inc. Morphogen-induced dendritic growth
US6287816B1 (en) 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
WO1993009229A1 (en) 1991-11-04 1993-05-13 Genetics Institute, Inc. Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
DK0625989T3 (da) 1992-02-12 2000-06-26 Bioph Biotech Entw Pharm Gmbh DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
CA2147598A1 (en) 1992-11-03 1994-05-11 Stryker Corporation Op-3-induced morphogenesis
CA2153653C (en) 1993-01-12 2010-12-07 Se-Jin Lee Growth differentiation factor-9
EP0690871A4 (en) 1993-01-12 1999-10-20 Univ Johns Hopkins Med GROWTH DIFFERENTIATION FACTOR-5
DK0690873T3 (da) 1993-03-19 2003-09-29 Univ Johns Hopkins Med Vækstdifferentieringsfaktor-8
WO1994026892A1 (en) 1993-05-12 1994-11-24 Genetics Institute, Inc. Bmp-11 compositions
JPH09501305A (ja) 1993-05-12 1997-02-10 ジェネティックス・インスティテュート・インコーポレイテッド Bmp−10組成物
WO1995001801A1 (en) 1993-07-09 1995-01-19 The Johns Hopkins University School Of Medicine Growth differentiation factor-6
US6204047B1 (en) 1993-10-08 2001-03-20 The Johns Hopkins University School Of Medicine Growth differentiation factor-10
JP3300500B2 (ja) 1993-10-12 2002-07-08 新日本製鐵株式会社 疲労強度、降伏強度および被削性に優れる熱間鍛造用鋼の製造方法
DE4334646C1 (de) 1993-10-12 1994-09-29 Quinting Friedhelm Durchsichtige Analog-Zeituhr
AU689184B2 (en) 1993-12-07 1998-03-26 Genetics Institute, Llc BMP-12, BMP-13 and tendon-inducing compositions thereof
US5399677A (en) 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
IL114397A0 (en) 1994-07-01 1995-10-31 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF-beta-family
EP1574577A3 (en) 1994-07-08 2006-06-14 The Johns Hopkins University School Of Medicine Growth differentiation factor-11
AU1120295A (en) 1994-11-07 1996-05-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cartilage-derived morphogenetic proteins
US5635372A (en) 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
EP0894004B2 (en) 1996-03-22 2007-02-21 Curis, Inc. Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma
US6498142B1 (en) 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
US6958149B2 (en) 1998-10-06 2005-10-25 Stryker Corporation Repair of larynx, trachea, and other fibrocartilaginous tissues
US6846906B1 (en) 1998-10-07 2005-01-25 Stryker Corporation Modified proteins of the TGF-β superfamily, including morphogenic proteins
US6677432B1 (en) 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
CA2345024C (en) 1998-10-07 2009-05-19 Stryker Corporation Modified tgf-.beta. superfamily proteins
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
US8154581B2 (en) 2002-10-15 2012-04-10 Revolutionary Concepts, Inc. Audio-video communication system for receiving person at entrance
EP1692505B1 (en) * 2003-11-03 2012-09-05 Danisco US Inc. Cd4+ epitopes of bone morphogenetic proteins
CA2561809A1 (en) * 2004-03-31 2005-10-20 Xencor, Inc. Bmp-7 variants with improved properties
WO2005113585A2 (en) 2004-05-20 2005-12-01 Acceleron Pharma Inc. Modified tgf-beta superfamily polypeptides
CA2567405A1 (en) 2004-05-25 2005-12-08 Stryker Corporation Use of morphogenic proteins for treating cartilage defects
WO2007087053A2 (en) 2005-12-22 2007-08-02 Centocor, Inc Bmp-7 variant compositions, methods and uses
US7659250B2 (en) * 2005-12-22 2010-02-09 Centocor, Inc. BMP-7 variant compositions, methods and uses
WO2008051526A2 (en) * 2006-10-23 2008-05-02 Stryker Corporation Bone morphogenetic proteins
JP5529754B2 (ja) * 2007-12-21 2014-06-25 ストライカー コーポレイション Nogginに対する感受性が低下したBMP変異体
JPWO2010117047A1 (ja) 2009-04-10 2012-10-18 株式会社ニコン 光学材料、光学素子、及びその製造方法
JP2011211450A (ja) 2010-03-30 2011-10-20 Victor Co Of Japan Ltd 立体映像表示装置、立体映像撮像装置および立体映像表示方法
US9507084B2 (en) 2010-12-03 2016-11-29 Ofs Fitel, Llc Single-mode, bend-compensated, large-mode-area optical fibers designed to accomodate simplified fabrication and tighter bends
US8886307B2 (en) 2012-01-30 2014-11-11 Medtronic, Inc. Adaptive cardiac resynchronization therapy
WO2013183270A1 (ja) 2012-06-07 2013-12-12 旭化成エレクトロニクス株式会社 位置検出装置
US9298469B2 (en) 2012-06-15 2016-03-29 International Business Machines Corporation Management of multiple nested transactions
US9405290B1 (en) 2013-01-17 2016-08-02 Kla-Tencor Corporation Model for optical dispersion of high-K dielectrics including defects
JP6154215B2 (ja) 2013-06-28 2017-06-28 株式会社日立国際電気 半導体装置の製造方法、基板処理装置およびプログラム
US9170581B2 (en) 2013-09-30 2015-10-27 Crown Equipment Limited Industrial vehicles with overhead light based localization
JP6541301B2 (ja) 2014-03-28 2019-07-10 キヤノン株式会社 ロボット装置、ロボット装置の制御方法、ロボット制御プログラム、及び記録媒体
US9411440B2 (en) 2014-08-22 2016-08-09 Qualcomm Incorporated Digital ultrasonic emitting base station
US9407762B2 (en) 2014-10-10 2016-08-02 Bank Of America Corporation Providing enhanced user authentication functionalities
US9412814B2 (en) 2014-12-24 2016-08-09 Taiwan Semiconductor Manufacturing Co., Ltd. Structure and formation method of FinFET device
US9400685B1 (en) 2015-01-30 2016-07-26 Huawei Technologies Co., Ltd. Dividing, scheduling, and parallel processing compiled sub-tasks on an asynchronous multi-core processor

Similar Documents

Publication Publication Date Title
JP2020507347A5 (https=)
EA201300054A1 (ru) Полипептид, обладающий активностью бета-глюкозидазы, и его применение
MX2018011384A (es) Arn de replicacion en trans.
EP2470559A4 (en) COAGULATION FACTOR IX COMPOSITIONS AND METHODS OF MAKING AND USING THEM
EA200800368A1 (ru) Гликозилированный il-7, получение и применение
MY188897A (en) Factor viii compositions and methods of making and using same
SA522433360B1 (ar) L-أَسْباراجيناز مُعدل
MX2009008118A (es) Polipeptido e2 del virus del papiloma usado para vacunacion.
JP2013523718A5 (https=)
JP2011528332A5 (https=)
JP2024180560A5 (https=)
JP2009508471A5 (https=)
JP2018537089A5 (https=)
CN101514231B (zh) 靶向性抗血栓形成的融合蛋白及其制备方法和应用
NZ602693A (en) Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
JP2023507575A5 (https=)
JPWO2019156137A5 (https=)
JP2020172505A5 (https=)
JP2014529399A5 (https=)
JP2013514811A5 (https=)
MY167485A (en) Recombinant human interferon-like proteins
JP2017503505A5 (https=)
MX2022007546A (es) Interferon-alfa-2 modificado que tiene inmunogenicidad reducida.
EA201300059A1 (ru) Полипептид, обладающий активностью сволленина, и его применение
RU2007103735A (ru) Детоксифизим с активностью преобразования афлатоксина и ген, кодирующий детоксифизим